Abstract Streptomyces nodosus produces the antifungal polyene amphotericin B. Numerous modifications of the amphotericin polyketide synthase have yielded new analogues. However, previous inactivation of the ketoreductase in module 10 resulted in biosynthesis of truncated polyketides. Here we show that modules downstream of this domain remain intact. Therefore, loss of ketoreductase-10 activity is sufficient to cause early chain termination. This modification creates a labile point in cycle 11 of the polyketide biosynthetic pathway. Non-extendable intermediates are released to accumulate as polyenyl-pyrones.
Introduction
Amphotericin B 1 (Fig. 1 ) is used in clinical medicine for treatment of serious systemic fungal infections and visceral leishmaniases. It is obtained from fermentation cultures of Streptomyces nodosus. Both chemical modification and engineered biosynthesis have generated analogues with reduced toxicity . The aglycone 19-deoxy-19-oxo-amphoteronolide B 2 (Fig. 1 ) has potential as a starting material for chemical synthesis of derivatives with altered sugar residues. Small quantities of this compound have been obtained by chemical deglycosylation of amphotericin B (Kennedy et al. 1988 ). Biosynthesis of 19-deoxy-19-oxo-analogues was expected to result from inactivation of ketoreductase (KR) domain 10 of the amphotericin polyketide synthase (PKS) (Caffrey et al. 2001 ). However, we recently found that DKR10 mutants of S. nodosus produce truncated polyketide intermediates instead of full-length macrolactones ( Fig. 1) (Murphy et al. 2010 ). The KR10-1 strain synthesised the pentaenyl-pyrone 3 as a single product whereas the KR10-2 strain gave both the heptaenyl-pyrone 4 and the tetraenyl-pyrone 5 (Fig. 1 ). These new compounds were produced in good yields of up to 20 mg purified material per litre of culture. Preliminary PCR analysis of strain KR10-1 suggested that modules 5 and 6 had been precisely deleted from the AmphC protein that synthesises most of the polyene unit. This unexpected recombination event was not related to targeted replacement of the KR10 coding sequence, which is located at an approximate distance of 80 kb along the chromosome. The loss of these two modules accounts for the shorter chain length of pentaenyl-pyrone 3. Module 5 contains a partly functional enoylreductase domain (Caffrey et al. 2001 ) that causes formation of both heptaene 4 and tetraene 5 by strain KR10-2.
From the structures of the new pyrone compounds, it can be deduced that no ketoreduction occurs during cycle 10, as expected for a KR10 mutant (Fig. 2) . The unprocessed b-ketoacyl chains migrate from ACP10 to KS11 and incorporation of methylmalonyl CoAderived extender units gives polyenyl-2-methyl-3,5-diketoacyl-ACP11 thioester intermediates (Fig. 2) .
These products undergo no further enzymatic processing, and are released to accumulate as pyrones. This finding was unexpected because inactivation of KR12 or KR16 did not block subsequent steps in polyketide chain assembly (Power et al. 2008) . The co-incidental loss of two AmphC modules from strain KR10-1 raised the possibility that early termination might result from further unplanned deletions downstream of ACP11. This led us to characterise these strains more extensively. Here we show that the remaining PKS is intact. KR10 inactivation alone is sufficient to stall polyketide biosynthesis immediately after chain elongation by module 11. 
Materials and methods
Growth of S. nodosus strains and spectrophotometric analysis of polyenyl-pyrones was carried out as described previously (Murphy et al. 2010) . Genomic DNA was purified using Qiagen Genomic-tip 500/G ion-exchange columns. Oligonucleotide primers were obtained from MWG Biotech. Genome sequencing was carried out by BaseClear, Leiden, The Netherlands, using an Illumina Genome Analyser GAIIx. Direct sequencing of amplified DNA by the dideoxy method was carried out by Source BioScience, Ireland Sequencing Service, Dublin. PCR products were purified using a Qiagen QIAquick kit. The Artemis programme (downloaded from http://www. sanger.ac.uk/resources/software/artemis/) was used for final assembly of the re-sequenced amphI region of strain KR10-1.
Results and discussion

Analysis of AmphI domains in KR10-1 and KR10-2 strains
In KR10-deficient mutants, module 11 incorporates a branched extender unit into the polyketide chain. Since this elongation stage proceeds normally, the lack of ketoreduction in cycle 11 was unexpected. To investigate whether KR11 was intact, the DNA specifying this domain was amplified from strains KR10-1 and KR10-2 and both PCR products were resequenced. The PCR primers KR11F and KR11R (Supplementary Table 1 ) were designed to amplify the regions coding for the N-and C-terminal interdomain linkers as well as the enzymatic domain. This sequence data showed that no mutations were present in the KR11 domains of either strain. To investigate whether deletions had occurred downstream of module 11, further PCR analysis was carried out on coding sequences for domains within downstream modules (ACP11, KS12, AT12, ACP12, KS13, AT13, KR13, ACP13, ACP14). (The primers used are listed in Supplementary Table 1.) Analysis of amplified DNA by agarose gel electrophoresis indicated that all coding sequences were present in KR10-1 and KR10-2 strains ( Supplementary Fig. 1 ). More thorough analysis of strain KR10-1 was then carried out as described below.
Re-sequencing modules 11-14 in strain KR10-1
The AmphI protein contains modules 9-14 of the amphotericin PKS. The structures of the polyenyl-pyrones show that the DKR10 PKSs function as expected up to module 10. As next-generation sequencing technology has become affordable, we used this approach to investigate more fully whether the downstream AmphI modules 11-14 remain intact. Our previous work has shown that targeted deletion of modules 5 and 6 leads to production of pentaene macrolactone analogues of amphotericin B in high yield (Carmody et al. 2004; Murphy et al. 2010) . This shows that deletion of these two modules is not relevant to early chain termination in KR10-1. However, this strain was selected for re-sequencing so that the spontaneous amphC deletion could be investigated as well as the modules downstream of KR10.
Genomic DNA from strain KR10-1 was sent to BaseClear for sequencing. De novo assembly provided 3977 contig sequences with an average size of 1818 nucleotides. (In a separate study, we are currently sequencing and annotating the wild-type S. nodosus genome.) A second assembly of the strain KR10-1 sequence data was carried out using our unpublished S. nodosus genome sequence as a reference. This gave most of the strain KR10-1 amphI gene region coding for modules 11-14, although several small gaps remained. These regions were amplified by PCR ( Supplementary Fig. 2 ) and directly sequenced by the dideoxy method. The KR10-1 coding sequence for AmphI modules 11-14 was re-sequenced completely. The sequence of this region of the protein (amino acid residues 3128-9510) was identical to that first published for the amphotericin PKS (Caffrey et al. 2001 ) with the following exception: R
6381
?A in ACP12. This difference is also present in the S. nodosus genome sequence and does not affect amphotericin production; it is thought to represent a neutral substitution or an error in the original sequence. Analysis of the KR10-1 genome indicated that the downstream AmphJ and AmphK PKS proteins were intact, although small gaps in the corresponding gene sequences were not closed. The re-sequencing also revealed the precise location of the deletion in the amphC gene (see below).
These results show that early termination occurs even though the programmed pathway specifies b-ketoreduction by KR11 and further extension by downstream modules. There are no clear precedents where inactivation of a KR domain in one module prevents ketoreduction by the next. KR16 and KR12 mutants formed 3,5 diketoacyl and 3,5,7-triketoacyl intermediates, respectively, that are extended to form full length macrolactones (Power et al. 2008) . The behaviour of the DKR10 amphotericin PKSs is therefore surprising.
Proposed mechanisms for early termination in KR10-deficient PKSs
Module 11 normally generates a (2S, 3S)-2-methyl-3-hydroxyacyl-ACP product. The landmark study of Weissmann et al. (1997) first revealed the stereochemical aspects of such a cycle. A (2S)-methylmalonyl extender unit is loaded and incorporated, with inversion of stereochemistry, to give a (2R)-2-methyl-3-ketoacyl-ACP11. This undergoes epimerisation, via an enol intermediate, to give a (2S)-2-methyl-3-ketoacyl intermediate that is reduced to a (2S, 3S)-2-methyl-3-hydroxyacyl product. The epimerase activity has not been identified for any PKS module but is thought to reside within the KR domain (Valenzano et al. 2009 ). In a reconstituted module lacking an epimerase, the C-2 proton of a (2R)-2-methyl-3-ketoacyl-thioester is protected by the ACP domain and is not exchangeable (Castonguay et al. 2007 ). Our results suggest that in the unnatural tricarbonyl-ACP11 intermediate, the C-4 protons are labile and this allows tautomerisation of the C-5 ketone. The early enolisation stage of C-2 epimerisation then generates a dienol intermediate that is abnormally stable because it forms an extended system of conjugated double bonds. This is not a substrate for KR11 and is not accepted by KS12. This stalled polyketide intermediate might be off-loaded from the enzyme by the discrete AmphE thioesterase (TE) (Fig. 3, Route 1) . These editing TEs mainly recognise decarboxylated extender units attached to ACP domains but can also remove non-extendable polyketide intermediates (Heathcote et al. 2001) . The linear acyl chain would form a terminal pyrone ring spontaneously. Alternatively, cis-enolisation of the tricarbonyl chain may favour concerted pyrone formation and thioester cleavage, thus bringing about efficient chain release without intervention of a TE (Fig. 3, Route 2) . A cis geometry has been proposed for enolate intermediates that eventually form (2S 3S)-2-methyl-3-hydroxyacyl-ACP thioesters such as the product of AmphI module 11 (Starcevic et al. 2007) .
With future work, it may still be possible to engineer the biosynthesis of 19-deoxy-19-oxo-amphoteronolides. Mutations in module 11 that abolish the C-2 epimerase activity might allow reduction by KR11 and formation of full-length macrolactones with reversed alkyl group stereochemistry at C-16.
Iterative type I fatty acid and polyketide synthases are known to produce pyrones under abnormal conditions, such as the absence of modification enzymes or NADPH or S-adenosylmethionine cofactors. For example, incomplete lovastatin PKS systems synthesise a series of aberrant polyketides including polyenyl-pyrones of various chain lengths in vitro (Ma et al. 2009 ). Inactivation of amphotericin PKS domains KR6, KR7, KR8 and KR9 would also result in formation of shorter polyenyl-3,5-diketoacyl intermediates. It seems unlikely that these would form non-extendable dienol intermediates because non-epimerising modules are thought to prevent loss of the C-2 proton from the b-ketoacyl-ACP products. However, we plan to investigate this further by determining whether inactivation of KR7, KR8 or KR9 causes stalling of chain growth and accumulation of polyenyl-pyrones.
Mapping of the amphC deletion in strain KR10-1
This work also provides information on the evolution of natural product biosynthetic genes. In addition to finding that replacing a KR10 active site residue causes a drastic change in final product structure, we observed contraction of a heptaene synthase to a pentaene synthase. The genome resequencing suggested that the internal deletion in the KR10-1 amphC gene involves a 47-bp stretch that is directly repeated within the coding sequences for AT5 and AT7 (nucleotides 92165-92211 and 103628-103674, respectively, in sequence accession number AF357202). To confirm this, PCR primers M5F and M7R were designed to match AT5 and AT7 coding sequences flanking the putative deleted region. Direct sequencing of the product confirmed that the recombination had indeed generated an AT5/AT7 hybrid coding sequence, with the fusion point located within the repeated 47 bp sequence ( Supplementary Fig. 3 ). In a previous study (Carmody et al. 2004 ) genetic engineering was used to construct a pentaene macrolactone synthase in which the C-terminal region of KS5 was fused to the interdomain linker preceding AT7. (The coding sequences were joined through KpnI sites representing nucleotides 91698-91703 and nucleotides 103146-103151 in sequence accession AF357202). Extensive screening was required to obtain this gene replacement mutant, indicating that this region does not form a recombination hot-spot. Since the amphotericin PKS genes are stable in wild-type S. nodosus, it is unclear why the amphC gene should undergo a spontaneous deletion in the KR10-1 strain. Recombination between directly repeated homologous sequences may have resulted by chance through incorrect repair of a double-strand break. Since 3, 4 and 5 are of no obvious benefit to the S. nodosus producer strains, continued propagation would presumably result in silencing or inactivation of these clusters by mutation. However, polyenylpyrone production remained stable when the DKR10 strains were passaged through seven subcultures. Fig. 3 Proposed mechanisms for early chain termination in DKR10 strains. Biosynthetic cycles 10 and 11 are shown. The b-ketone formed by module 10 is unprocessed by the inactivated KR10 domain (shaded). Incorporation of a propionyl extender by module 11 gives a (2R)-2-methyl-3-ketoacyl-ACP11. This would be expected to undergo C-2 epimerisation and ketoreduction to give a (2S, 3S)-2-methyl-3-hydroxyacylchain that migrates from ACP11 to KS12. The first stage of C-2 epimerisation gives an enol intermediate that is unusually stable because the unnatural C5 ketone tautomerises to extend fully the system of conjugated double bonds. The resulting dienol intermediate is not reduced by KR11 or accepted by KS12. Two mechanisms for chain release are suggested. Route 1 Release by an editing TE gives a free acid that spontaneously isomerises and forms a pyrone. Route 2 Removal of the C-2 proton gives an intermediate containing a cis enol. This adopts a conformation that leads to concerted thioester cleavage and pyrone formation without intervention of a TE Biotechnological potential of polyenyl-pyrone producer strains Numerous bioactive polyketides terminate with 2-pyrone groups that presumably protect linear chains from degradation by b-oxidation (McGlacken and Fairlamb 2005) . Many of these compounds are biologically active and the polyenylpyrone group includes cytoprotectants, antioxidants, antibacterials and anticancer agents (Clark and Murphy 2009; Coleman and Waleza 2006) . The starter unit for these polyketides is critical for activity. The KR10-deficient amphotericin PKSs should also be useful for precursor-directed biosynthesis of valuable analogues.
Conclusions
Further work will be required to elucidate fully the precise mechanism for early chain termination. However, the present results prove that inactivation of KR10 introduces a labile point at a later stage in the amphotericin PKS pathway. The production of tetraenyl-, pentaenyl-and heptaenyl-pyrones suggests that the corresponding domain may be critical in polyene PKSs in general. This work has uncovered a restriction on the theoretical number of polyene macrolactone analogues that can be generated by engineered biosynthesis.
